OPTUS Pharmaceutical Co., Ltd. (KOSDAQ: 131030)

OPTUS Pharmaceutical Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	77,791	72,426	58,658	57,316	60,827	60,441
Other Revenue	-0	-0	-	-	-	-
Revenue	77,791	72,426	58,658	57,316	60,827	60,441
Revenue Growth (YoY)	22.79%	23.47%	2.34%	-5.77%	0.64%	21.80%
Cost of Revenue	34,776	31,072	27,041	24,821	22,531	23,547
Gross Profit	43,015	41,354	31,617	32,495	38,296	36,894
Selling, General & Admin	31,631	30,623	24,138	20,589	21,588	20,212
Research & Development	1,783	1,384	1,343	1,110	821.84	1,148
Other Operating Expenses	203.84	164.19	184.49	110.92	107.83	82.82
Operating Expenses	34,728	33,168	26,368	22,023	23,489	21,705
Operating Income	8,287	8,187	5,249	10,472	14,808	15,189
Interest Expense	-111.4	-124.4	-85.89	-8.88	-17.61	-3.95
Interest & Investment Income	2,447	2,296	1,401	846.43	1,137	1,348
Currency Exchange Gain (Loss)	-1.96	3.33	12.17	127.54	-17.39	0.32
Other Non Operating Income (Expenses)	-8.34	11.79	21.69	-36.76	105.62	-417.62
EBT Excluding Unusual Items	10,613	10,374	6,598	11,400	16,015	16,116
Gain (Loss) on Sale of Investments	952.51	1,967	73.39	-	2,505	364.96
Gain (Loss) on Sale of Assets	729.69	629.3	878.29	44.24	-18.97	-59.69
Asset Writedown	-	-	-721.2	-964.98	-	-
Pretax Income	12,295	12,970	6,828	10,479	18,502	16,421
Income Tax Expense	2,047	2,210	1,816	587.88	4,097	1,825
Net Income	10,248	10,760	5,012	9,892	14,405	14,596
Net Income to Common	10,248	10,760	5,012	9,892	14,405	14,596
Net Income Growth	35.60%	114.69%	-49.33%	-31.33%	-1.31%	45.92%
Shares Outstanding (Basic)	15	15	16	16	16	16
Shares Outstanding (Diluted)	15	15	16	16	16	16
Shares Change (YoY)	-1.41%	-4.22%	-1.07%	-0.62%	-1.20%	0.05%
EPS (Basic)	672.26	708.35	316.00	617.00	893.00	894.00
EPS (Diluted)	672.26	708.35	316.00	617.00	893.00	894.00
EPS Growth	37.54%	124.16%	-48.78%	-30.91%	-0.11%	45.84%
Free Cash Flow	11,074	9,109	-3,955	-3,557	11,603	13,025
Free Cash Flow Per Share	726.47	599.63	-249.37	-221.86	719.32	797.76
Gross Margin	55.30%	57.10%	53.90%	56.69%	62.96%	61.04%
Operating Margin	10.65%	11.30%	8.95%	18.27%	24.34%	25.13%
Profit Margin	13.17%	14.86%	8.54%	17.26%	23.68%	24.15%
Free Cash Flow Margin	14.24%	12.58%	-6.74%	-6.21%	19.08%	21.55%
EBITDA	12,246	12,424	8,712	12,895	17,392	17,809
EBITDA Margin	15.74%	17.15%	14.85%	22.50%	28.59%	29.46%
D&A For EBITDA	3,959	4,238	3,463	2,423	2,585	2,620
EBIT	8,287	8,187	5,249	10,472	14,808	15,189
EBIT Margin	10.65%	11.30%	8.95%	18.27%	24.34%	25.13%
Effective Tax Rate	16.65%	17.04%	26.60%	5.61%	22.14%	11.11%
Advertising Expenses	-	1,515	364.81	100.36	70.72	130.21

Source: S&P Capital IQ. Standard template. Financial Sources.